http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Corporate Social Responsibility and Financial Performance
김진욱(Kim, Jin-Uk),정성곤(Chung, Sunggon),박청규(Park, Cheongkyu) 한국산학기술학회 2013 한국산학기술학회논문지 Vol.14 No.11
본 논문은 기업의 사회적 책임이 재무성과에 영향을 미치는지를 고찰하였다. 선행연구들은 지금까지 일관적 이지 않은 결과를 보여주었으며, 본 연구는 기업의 사회책임이 기업의 재무성과에 긍정적인 영향을 미친다는 것을 발 견하였다. 모건스탠리에서 발간되는 한국기업의 사회적 책임 성과평가 자료를 분석한 결과, 기업의 사회적 책임과 자 본시장에서의 재무성과 간에 양의 상관관계가 있음을 발견하였다. 구체적으로 회귀분석의 결과 기업의 사회책임 평가 가 한 단계 높으면 주가수익률이 평균 3.4% 정도 높은 것으로 나타났다. 본 연구의 결과는 다른 나라의 자료를 토대 로 하는 선행연구의 결과를 지지하며, 한국기업의 사회적 책임에 대한 체계적이고 분석적인 평가 결과를 제공하였다 는 데에 의의가 있다. This study investigates how the Corporate Social Responsibility (CSR) performance of a firm is associated with its financial performance in the stock market. Prior studies provide mixed evidence on the relation between CSR and financial performance. This study sheds some lights on the positive effect of CSR on firms’ financial performance. Using a unique set of data on CSR performance of Korean firms provided by Morgan Stanley Capital International (MCSI), we find that firms’ CSR performance is positively associated with their contemporaneous stock returns and Tobin’s Q in the Korean market. This finding suggests that stock market participants value firms’ CSR activities. This is the first study that provides empirical evidence on the existence of the positive association between the CSR performance of Korean firms and their financial performance using MCSI data which is considered more reliable than the data used in the prior CSR studies in Korea.
윤성환,김문진,정광,정성곤,국민석,박홍주,오희균,김수관,김영균,조용석,김우철,양천모,김명인 대한치의학회 2013 Journal of korean dental science Vol.6 No.2
Purpose: The purpose of this study was to evaluate the survival and success rates of Korean Osstem implants US IIPlus, GS II following loading period. Materials and Methods: Dental records were obtained in total 201 patients who were treated with Korean Osstemimplants US II Plus, GS II on both maxillary and mandibular anterior and posterior areas in six different clinics for 2years from January 2007 to December 2008. Total 430 implants were evaluated clinically and radiographically usingpredefined success criteria prospectively and following results were obtained. Result: US II Plus, GS II implants showed high survival rates of more than 99% and high success rates more than 90%independent of loading period. As a result of cross analysis to evaluate clinical significance between implant loadingperiod and success rate, the P-value of US II Plus was 0.10 (P>0.05), and the P-value of GS II was 0.17 (P>0.05), whichshowed no statistical significance. Bone quality, smoking, and edentulous state are factors that can affect the survivaland success rates following differently loaded implants, but did not significantly affect in this study. Conclusion: These results suggest that selection of loading period of Korean Osstem implants US II Plus, GS IIwould be done carefully considering implant install area, the quality alveolar bone, the state of edentulous ridge andexperience of operator, though they showed clinically good results on both maxillary and mandibular anterior andposterior areas.
Capitalization of Research and Development
Cheong Kyu Park(박청규),Sung Gon Chung(정성곤),Jin Wook Kim(김진욱) 한국산학기술학회 2014 한국산학기술학회 학술대회 Vol.- No.-
This study investigates the effect of R&D capitalization on earnings variability. Investment in R&D plays a significant role in the world of business by leading to innovation, development, and the growth of business enterprises. However, the current accounting standards require corporations to expense the R&D costs as incurred. Accordingly, there has been a debate over the accounting treatment for such investment for decades. We calculate earnings (adjusted for R&D capitalization), as if the company’s R&D expenditures were capitalized during the period and compare it with reported earnings in financial statements. We find that earnings reported in the financial statements are variable when R&D spending changes significantly. It implies that the capitalization of R&D is more reliable.